Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.12 USD
Change Today 0.00 / 0.00%
Volume 0.0
AGGX On Other Exchanges
As of 8:10 PM 08/19/15 All times are local (Market data is delayed by at least 15 minutes).

angiogenex inc (AGGX) Snapshot

Previous Close
Day High
Day Low
52 Week High
11/18/14 - $0.22
52 Week Low
10/24/14 - $0.10
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ANGIOGENEX INC (AGGX)

Related News

No related news articles were found.

angiogenex inc (AGGX) Related Businessweek News

No Related Businessweek News Found

angiogenex inc (AGGX) Details

AngioGenex, Inc., a biopharmaceutical company, discovers and develops products for the treatment, diagnosis, and prognosis of cancer. The company offers anti-cancer molecules that act by inhibiting either the inhibitor of differentiation (Id) genes or proteins to prevent the formation of new blood vessels into tumors (angiogenesis). It also provides anti-Id drugs, diagnostic/prognostic /surrogate marker tests, and solutions for use of anti-Id therapy in non-cancer indications. The company was incorporated in 1999 and is based in New York, New York.

angiogenex inc (AGGX) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: --
Co-Founder, Chairman and President
Total Annual Compensation: --
Controller and Director
Total Annual Compensation: --
Vice President of Corporate Communications & ...
Total Annual Compensation: --
Director of Business Development
Total Annual Compensation: --
Compensation as of Fiscal Year 2015.

angiogenex inc (AGGX) Key Developments

AngioGenex, Inc. Presents at The Trout Group 's Annual 1x1 Management Access Event, Jan-12-2015

AngioGenex, Inc. Presents at The Trout Group 's Annual 1x1 Management Access Event, Jan-12-2015 . Venue: The Handlery Hotel, 351 Geary Street, Union Square, San Francisco, California, United States.

Dr. Robert Benezra to Join AngioGenex, Inc.'s Board of Directors

AngioGenex, Inc. announced that Dr. Robert Benezra will join the company's Board of Directors effective immediately.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AGGX:US $0.12 USD 0.00

AGGX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AGGX.
View Industry Companies

Industry Analysis


Industry Average

Valuation AGGX Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANGIOGENEX INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at